Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans
Most Cited Paper
in HIV Research and Treatment
18 Months Post-Publication
Class of 2026
“Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/hiv-research-and-treatment/2026/
Topics
Broadly neutralizing antibodies (bNAbs) · Broadly neutralizing antibodies (bNAbs) · HIV vaccine · B cell lineage · HVTN 133 clinical trial · MPER · MPER · HIV vaccine · HIV-1 Envelope glycoprotein · tier 2 HIV-1 strains · clade B strains · improbable mutations · Heterologous virus neutralization · HIV-1 Envelope glycoprotein · Vaccine-induced antibodies · antibody-lipid binding · somatic hypermutation · polyclonal antibody responses
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited HIV Research and Treatment Papers, Class of 2026. https://pri.pepkio.com/top-papers/hiv-research-and-treatment/2026. Accessed 2026-07-21. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459